U.S. markets open in 7 hours 8 minutes

Odyssey Group International, Inc. (ODYY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.1100-0.0900 (-7.50%)
At close: 3:56PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.2000
Open1.2000
BidN/A x N/A
AskN/A x N/A
Day's Range0.9800 - 1.2450
52 Week Range0.2000 - 2.0000
Volume56,084
Avg. Volume195,635
Market Cap100.533M
Beta (5Y Monthly)1.72
PE Ratio (TTM)N/A
EPS (TTM)-0.0410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • ACCESSWIRE

      Odyssey Group International, Inc. Closes Acquisition of Novel Concussion Drug

      Anticipates initiation of Phase 1 clinical trials of PRV-002 during the Second Quarter of 2021IRVINE, CA / ACCESSWIRE / March 2, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ("Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to announce that it has closed the previously announced acquisition of drug candidate PRV-002, a novel neurosteroid being developed for the treatment of concussion (mild traumatic brain injury (mTBI)), from Prevacus, Inc.

    • ACCESSWIRE

      Odyssey Group International Completes Design Phase and Moves Into Prototype Phase for Its Save A Life Choking Rescue Device

      Targets FDA SubmissionIRVINE, CA / ACCESSWIRE / February 24, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to announce that its collaboration with Tanaka Kapec Design Group (TKDG) has led to the completion of the design development phase for its Save A Life choking rescue device.

    • ACCESSWIRE

      Odyssey Group International/Prevacus, Inc. Reports Brain Bio-Distribution Findings of PRV-002

      Pre-clinical data for PRV-002, a nasally delivered drug in development for treating concussion, highlight rapid brain bioavailabilityIRVINE, CA / ACCESSWIRE / February 17, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ("Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, and Prevacus Inc.